| 1 |
29581235 | Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis. | 2018 May 11 |
1 |
| 2 |
27184954 | Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine. | 2016 Aug |
2 |
| 3 |
27220420 | Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke. | 2016 May 24 |
2 |
| 4 |
24436331 | Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium. | 2014 Feb 28 |
3 |
| 5 |
23956444 | Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. | 2013 Nov |
1 |
| 6 |
20305660 | Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. | 2010 Apr |
3 |
| 7 |
16014720 | Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. | 2005 Jul 13 |
2 |
| 8 |
12021246 | Myeloperoxidase produces nitrating oxidants in vivo. | 2002 May |
1 |
| 9 |
11593004 | Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. | 2001 Oct 9 |
1 |